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Multidrug/Multixenobiotic resistance (MDR/MXR) is a widespread phenomenon with
clinical, agricultural and biotechnological implications, where MDR/MXR transporters that
are presumably able to catalyze the efflux of multiple cytotoxic compounds play a key role
in the acquisition of resistance. However, although these proteins have been traditionally
considered drug exporters, the physiological function of MDR/MXR transporters and the
exact mechanism of their involvement in resistance to cytotoxic compounds are still open
to debate. In fact, the wide range of structurally and functionally unrelated substrates
that these transporters are presumably able to export has puzzled researchers for years.
The discussion has now shifted toward the possibility of at least some MDR/MXR
transporters exerting their effect as the result of a natural physiological role in the cell,
rather than through the direct export of cytotoxic compounds, while the hypothesis that
MDR/MXR transporters may have evolved in nature for other purposes than conferring
chemoprotection has been gaining momentum in recent years. This review focuses on
the drug transporters of the Major Facilitator Superfamily (MFS; drug:H+ antiporters)
in the model yeast Saccharomyces cerevisiae. New insights into the natural roles of
these transporters are described and discussed, focusing on the knowledge obtained
or suggested by post-genomic research. The new information reviewed here provides
clues into the unexpectedly complex roles of these transporters, including a proposed
indirect regulation of the stress response machinery and control of membrane potential
and/or internal pH, with a special emphasis on a genome-wide view of the regulation and
evolution of MDR/MXR-MFS transporters.
Keywords: Saccharomyces cerevisiae, multidrug/multixenobiotic resistance (MDR/MXR), MDR/MXR transporters,
Major Facilitator Superfamily (MFS), genome-wide approaches, transcriptional regulation, phylogenetic analysis
MULTIDRUG/MULTIXENOBIOTIC TRANSPORTERS OF THE
MAJOR FACILITATOR SUPERFAMILY IN THE MODEL YEAST
SACCHAROMYCES CEREVISIAE
THE MULTIDRUG/MULTIXENOBIOTIC RESISTANCE PHENOMENON
All living cells exhibit elaborate molecular mechanisms to pro-
tect themselves from external assault, such as the exposure to
drugs and other cytotoxic compounds. The simultaneous acquisi-
tion of resistance to a wide range of structurally and functionally
unrelated cytotoxic chemicals has become a widespread phe-
nomenon in nature known as Multidrug/Multixenobiotic resis-
tance (MDR/MXR) (Gulshan and Moye-Rowley, 2007; Higgins,
2007; Nikaido, 2009; Sá-Correia et al., 2009). MDR/MXR poses
a severe problem at the clinical and agricultural levels, being
involved in the failure of cancer therapy and treatment of infec-
tious diseases, as well as food preservation and crop protec-
tion strategies, due to the emergence of resistant cancer cell
lines, pathogenic strains, and resistant weed species (Prasad and
Kapoor, 2005; De Waard et al., 2006; Szakács et al., 2006; Hall
et al., 2009; Morschhauser, 2010).
Although drug resistance might be mediated by various mech-
anisms, membrane transporters that presumably catalyze the
efflux of a broad range of cytotoxic substrates play an important
role in MDR/MXR processes (Sá-Correia et al., 2009; Sherlach
and Roepe, 2014). Such MDR/MXR pumps can presumably rec-
ognize a wide variety of unrelated compounds that are usually
not present in the cell’s natural environment, maintaining the
intracellular drug/xenobiotic concentration below its toxic level
and thus providing chemoprotection from those compounds (del
Sorbo et al., 2000; Higgins, 2007; Prasad and Goffeau, 2012).
Several MDR/MXR families of transporters have been identi-
fied and studied in different types of cells, however only two are
known to occur commonly in all classes of organisms: the ATP-
binding cassette (ABC) superfamily and the Major Facilitator
Superfamily (MFS) (Higgins, 2007; Sá-Correia et al., 2009). MFS
transporters, the focus of this review, are ubiquitous single-
polypeptide secondary carriers capable only of transporting small
solutes in response to chemiosmotic ion gradients. However, in
some cases, MFS transporters are also believed to act as Drug:H+
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Antiporters (DHA) and confer MDR/MXR resistance in bacteria,
fungi and more complex eukaryotes.
MDR/MXR transporters have puzzled researchers for a long
time, but their refractoriness to purification and crystallization
has handicapped the elucidation of the mechanisms behind their
action. Plus, the genome of one single cell can encode multiple
MDR/MXR transporters, some of which are apparently redun-
dant (Paulsen, 2003; Higgins, 2007). The high number of these
transporters is a clear indication that MDR/MXR mediated by
efflux pumps is not an exceptional phenomenon, but a highly
conserved defense mechanism. Importantly, most multidrug
transporters share significant homology with other transporters
with well-characterized natural substrates (Paulsen, 2003). As
such, many questions still await answers, one of the most impor-
tant pertaining to the normal physiological function of these
so-called “drug efflux pumps” (Roepe, 2000; Panwar et al., 2008;
Sá-Correia et al., 2009; Sherlach and Roepe, 2014): do they only
offer protection from cytotoxic agents, or did they evolve in
nature for other purposes? Do they have relevant physiological
substrates and only extrude toxic compounds opportunistically?
Is their role in drug resistance effectively connected to direct drug
transport, as has been believed for years, or do they instead have
an indirect action in MDR/MXR?
Although the molecular mechanisms underlying the appar-
ent promiscuity of MDR/MXR transporters have remained a
long-standing topic of debate, recent findings, also derived from
genome-wide strategies, are shifting the discussion toward an
indirect role of, at least, some of these transporters inMDR/MXR,
in contrast to the more widely accepted drug-efflux pump model
(Vargas et al., 2007; Cabrito et al., 2011; Teixeira et al., 2011;
Dikicioglu et al., 2013; Kruger et al., 2013). Moreover, sev-
eral recent analyses have highlighted the correlation between
MDR/MXR and membrane lipid homeostasis (Pallares-Trujillo
et al., 2000; Panwar et al., 2008; Shahi and Moye-Rowley, 2009).
The coordinate control of lipid composition and drug trans-
port activities is required for normal multidrug resistance in
fungi and, indeed, the regulation of membrane composition by
MDR/MXR proteins provides an important contribution to the
resistant phenotypes observed. The altered partitioning model
is another interesting hypothesis that attempts to explain the
mode of action of MDR/MXR transporters (Roepe et al., 1996;
Sherlach and Roepe, 2014). It suggests that MDR/MXR proteins
do not directly transport drugs, but instead their altered expres-
sion results in the alteration of key parameters, which ultimately
leads to changes in the passive diffusion and/or action of cytotoxic
compounds. Understanding the exact physiological role of these
transporters, and how it relates to their action in MDR/MXR, is
of paramount importance to devise strategies to overcome clinical
multidrug resistance, achieve a more efficient uptake and utiliza-
tion of drugs, and improve stress tolerance in biotechnological
processes.
This review will focus on the physiological characterization
of MFS transporters involved in MDR/MXR in the model yeast,
and how the proposed physiological roles might be associated
with chemical stress resistance. We also discuss the potential of
genome-wide approaches, not only in the elucidation of spe-
cific biological roles but also in the unraveling of mechanisms
of transcriptional and post-translational control of the activity of
these transporters.
S. CEREVISIAE AS AN EXPERIMENTAL MODEL IN MDR/MXR
Yeast is a widely used eukaryotic model for molecular and cel-
lular biology studies. This unicellular non-pathogenic microor-
ganism is a robust and inexpensive experimental platform,
amenable to genetic manipulation, possesses a remarkable level
of functional conservation with higher eukaryotes, and its
genome has been extensively annotated with functional infor-
mation. But even more significantly, yeast has been used to
pioneer the development of several post-genomic experimental
approaches and computational tools, allowing the easy imple-
mentation of genome-wide analyses and the availability of a wide
range of experimental tools and biological material (Mager and
Winderickx, 2005; Smith et al., 2010; Botstein and Fink, 2011).
Moreover, althoughmany cytotoxic compounds of interest do not
exist in the natural environment of yeast, many of the basic mech-
anisms underlying adaptation and resistance to chemical and
other environmental stresses are apparently conserved between
yeast and phylogenetically distant organisms. As such, the use
of this model system can provide a deep level of understanding
on molecular mechanisms that would be harder to achieve in
more complex and less accessible eukaryotes. Furthermore, the
results emerging from studies on MDR/MXR and its regulation
in S. cerevisiae can be extended to pathogenic yeasts (e.g.,Candida
species) to guide the development of new prophylactic, diagnosis,
and therapeutic approaches to the rising number of drug resistant
fungal infections (see Costa et al. in this Research Topic and refs
Costa et al., 2013a,b, 2014).
The use of genome-wide (Omic) approaches has gained con-
siderable momentum in recent years. Remarkably, the identi-
fication of alterations occurring in gene or protein expression
following exposure to a drug or xenobiotic compound can con-
tribute to identify the cellular pathways that are most relevant to
the stress response, including MDR/MXR transporters and how
their complex regulation and putative physiological roles may also
influence drug resistance. Genomic/proteomic variations can be
identified through transcriptomics and quantitative proteomics.
Expression proteomic approaches are also important to identify
alterations at the level of post-translational modifications asso-
ciated with exposure to xenobiotic and cytotoxic compounds.
Another very important tool in yeast research are gene knockout
collections. Chemogenomic analyses to identify determinants of
resistance to a particular compound in yeast can be performed
using homozygous (knock-out deletions, gene dosage = 0%),
haploinsufficiency (heterozygous deletion strains, gene dosage =
50%) and multicopy- and overexpression (gene dosage > 100%)
collections. Many MDR/MXR transporters are directly linked
to the ability of cells to grow in the presence of a particular
stressing condition, and most of the compounds to which these
transporters provide protection have been identified through the
assessment of the fitness phenotypes of the corresponding dele-
tion mutants under chemical stress. In fact, under control condi-
tions these growth phenotypes are not detectable and would not
have been identified. Furthermore, in several cases the presence of
the gene is required for growth under a given stress, and yet there
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are no alterations at the expression or protein content level, mean-
ing that many of these conditions would not have been discovered
using expression-based methodologies such as DNA microar-
rays or proteomics. However, the identification of an MDR/MXR
transporter-encoding gene as a determinant of resistance does not
necessarily mean that the gene product is involved directly in the
efflux of that compound from the cell. As discussed in Section
The MDR/MXR Phenomenon, some of these transporters might
have natural physiological roles that indirectly enable chemopro-
tection, for example through the alteration of plasma membrane
potential and/or lipid composition. For this reason, lipidomic
analyses can also be of particular interest, given the role of sph-
ingolipids and ceramides as signaling mediators in a growing
number of pathways and in lipid-based signaling in the yeast
response to stress (Epstein and Riezman, 2013), in addition to
the effect of plasma membrane ergosterol content and membrane
lipid homeostasis in stress tolerance and drug resistance (Panwar
et al., 2008; Shahi and Moye-Rowley, 2009; Cabrito et al., 2011).
The identification of transcription factors and regulatory net-
works predicted to underlie the transcriptional regulation of
MDR/MXT transporters has been facilitated by freely accessi-
ble databases, such as YEASTRACT (http://www.yeastract.com)
(Teixeira et al., 2006, 2014). This information system contains
over 200,000 regulatory associations between transcription fac-
tors and target genes, including 326 DNA binding sites for
113 transcription factors. The most recent version includes fur-
ther information on the environmental conditions in which
each association was determined and whether the transcrip-
tion factor is acting on its target genes as activator or repres-
sor, enabling the development of a wide range of new queries
(Teixeira et al., 2014). More in-depth studies into the physio-
logical activity of MDR/MXR-MFS transporters can be designed
based on the knowledge obtained from the transcriptional net-
works governing the expression of these transporters in response
to specific stress conditions. Some examples retrieved from the
YEASTRACT database are discussed in Section Clues on the
Functional Analysis of DHA1/DAG Transporters Based on their
Transcriptional Regulation Under Environmental Challenges or
Stress.
THE MDR/MXR-RELATED SUBFAMILIES OF MFS TRANSPORTERS DHA1
AND DAG IN S. CEREVISIAE
Following the release of the full genome sequence of S. cerevisiae
(Goffeau et al., 1996), the similarity analysis of the amino acid
sequences encoded in the annotated ORFs led to the separation of
MDR/MXR-MFS encoded genes into 2 sub-families, depending
on whether their protein products contained 12 or 14 trans-
membrane segments (TMS): the 12-spanner drug:H+ antiporter
family 1 (DHA1) and the 14-spanner drug:H+ antiporter family
2 (DHA2) (Nelissen et al., 1995, 1997). The subsequent phyloge-
netic analysis of these protein sequences showed that they fell into
three major clusters, with cluster I comprising the 12-spanner
MDR/MXR-MFS transporters and clusters II and III compris-
ing the 14-spanner transporters. While cluster II included the
DHA2 family proteins, those in cluster III were assigned to the
Unknown Major Facilitator (UMF) family (Paulsen et al., 1998).
However, after the demonstration that four UMF family members
encoded siderophore transporters (Lesuisse et al., 1998; Heymann
et al., 1999, 2000a,b) and that the other two UMF family mem-
bers encoded glutathione exchangers (GEX) (Dhaoui et al., 2011),
these proteins were reassigned to the new ARN (also known as
the Siderophore-Iron Transporter/SIT family) and GEX families,
respectively (Yun et al., 2000; Haas et al., 2008; Dhaoui et al., 2011;
Dias and Sa-Correia, 2013). However, a recent analysis combining
phylogenetic and gene neighborhood approaches gathered evi-
dence supporting the hypothesis that the DHA2, ARN and GEX
proteins share a common root (Dias and Sa-Correia, 2013). A new
gene family, DAG (DHA2/ARN/GEX), was proposed to accom-
modate these three phylogenetic subfamilies of 14-spanner MFS
transporters (Figure 1; Tables 1, 2).
As in many other species, the prevalence and apparent redun-
dancy of these transporters in S. cerevisiae raises many questions,
most importantly what is the physiological function of these pro-
teins in the absence of drugs or stresses to which they confer
resistance? Although MDR/MXR-MFS genes are not essential,
they are encoded in the genome, and maintain basal expres-
sion levels when cells are not exposed to any stress. However,
the identification of the so-called physiological function of these
transporters is not trivial. Multispanner membrane transporters
are very difficult to purify, and reconstitution in lipid bilayer
preparations for direct functional assays presents many diffi-
culties (Ambudkar et al., 1998; Howard and Roepe, 2003). An
additional drawback is that the elimination of a membrane trans-
porter will often have an effect on the transport kinetics of other
transporters in the same cell, further complicating the functional
analysis of the corresponding deletion mutants. The phylogenetic
analysis of MDR/MXR-MFS transporters might shed light on the
physiological functions of these transporters, based on the idea
that amino acid conservationmight imply similar biological func-
tions, and in turn help elucidate the molecular mechanisms that
lead to multidrug resistance.
The DHA1 family
The DHA1 family in S. cerevisiae comprises 12 proteins, encoded
by AQR1, DTR1, FLR1, HOL1, QDR1, QDR2, QDR3, TPO1,
TPO2, TPO3, TPO4, and YHK8 (Table 1) (Sá-Correia et al., 2009;
Dias et al., 2010). The expression ofMDR transporters of theMFS
has been shown to confer resistance to a wide variety of chemical
stresses, ranging from anticancer and antimalarial drugs to weak
acids and herbicides (Sá-Correia et al., 2009). However, although
these transporters have been mostly studied within the context
of their role in multidrug resistance, physiological roles for many
DHA1 proteins have been proposed in recent years. In some cases,
as described below, these natural functions have been correlated
with the transporter’s ability to confer chemoprotection against a
given stress, consistent with the hypothesis of an indirect role in
drug resistance.
Dtr1 was one of the first DHA1 proteins that were shown to
have a physiological role other than chemoprotection. This trans-
porter was identified in a genome-wide screen for spore wall
mutants and was shown to be essential for its biosynthesis, by
facilitating the translocation of bisformyl dityrosine through the
prospore membrane during spore wall maturation (Felder et al.,
2002). Bisformyl dityrosine was therefore proposed as a natural
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FIGURE 1 | Phylogenetic tree constructed using the amino acid
sequences of DHA1 and DAG proteins encoded in the genome of the
model-organism S. cerevisiae. The multiple alignments of the protein
sequences were done using Muscle software and the tree was built using
the maximum likelihood package (PROTML) made available in the PHYLIP
software suite (Felsenstein, 1989; Edgar, 2004).
substrate of Dtr1, although the transporter was also shown to be a
determinant of resistance to several cytotoxic compounds (Felder
et al., 2002; Sá-Correia et al., 2009). Aqr1 was another one of
the first DHA1 family transporters to have a physiological role
assigned. This transporter has been demonstrated to be involved
in the excretion of amino acids, in particular homoserine and
threonine (Velasco et al., 2004), a role that might be particularly
relevant in the response to stress conditions leading to an abnor-
mal accumulation of amino acids. More recently, a genome-wide
study of DNA damage pathways in response to DNA replication
stress also found that Aqr1 relocalizes from the plasmamembrane
to the cytoplasm when cells are challenged with the replication
inhibitor hydroxyurea, suggesting that Aqr1 might be involved
in a pathway that responds to drug-induced DNA replication
stress (Tkach et al., 2012). The same study also showed that
Flr1 relocalizes from the nucleus (confirmed localization under
control conditions, although it does not match the localization
predicted by Huh et al., 2003) to the plasma membrane following
treatment with methylmethanesulfonate (MMS), an alkylating
agent that interferes with the action of replicative polymerases.
This observation is of particular interest since Flr1 is one of the
MDR/MXR-MFS transporters that is more clearly linked to drug
resistance, enabling yeast cells with increased resistance to a wide
range of unrelated drugs and other chemicals (Sá-Correia et al.,
2009), but a physiological substrate has not yet been described.
Although Qdr1 is a paralog of Aqr1, it was not implicated in the
response to replication stress (Tkach et al., 2012), nor does it have
a natural substrate assigned. However, a synthetic genetic array
analysis recently identified Qdr1 as a component of the com-
plex gene network that controls the assembly of the spore wall,
together with Dtr1 and Qdr3 (Lin et al., 2013).
Qdr2 has been proposed to contribute to potassium homeosta-
sis, possibly by functioning as an alternative K+ importer (Vargas
et al., 2007). This physiological function was proposed to play
an indirect role in the ability of this transporter to confer resis-
tance to quinidine (Vargas et al., 2004, 2007), a drug that leads
to decreased K+ uptake and a drop in the intracellular accumu-
lation of K+ in yeast cells (Vargas et al., 2007). QDR2 expression
was shown to confer a physiological advantage to cells during the
onset of K+ limited growth and in the presence of quinidine by
promoting K+ import (Vargas et al., 2007). Qdr2 has also been
isolated in a global screen for tolerance to lithium and sodium and
was proposed to participate in the uptake of cadmium and cobalt
(Rios et al., 2013). Furthermore, copper extrusion is impaired in
the qdr2 null mutant, leading to the proposal of divalent cop-
per as the main physiological substrate of Qdr2. This role in
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Table 1 | List of MDR/MXR-MFS transporters encoded in the genome of S. cerevisiae, belonging to the DHA1 family, gene product descriptions
are based on the information listed for each gene in the Saccharomyces Genome Database.a
Gene Name Gene product description
YNL065w AQR1 Confers resistance to short-chain monocarboxylic acids and quinidine; involved in the excretion of excess amino acids;
has a paralog, QDR1, that arose from the whole genome duplication; relocalizes from plasma membrane to cytoplasm
upon DNA replication stress; boron exporter
YBR180w DTR1 Putative dityrosine transporter; required for spore wall synthesis; sequence similarity to QDR1 and QDR3, and the triple
mutant dtr1 qdr1 qdr3 exhibits reduced dityrosine fluorescence relative to the single mutants; expressed during
sporulation
YBR008c FLR1 Involved in the efflux of fluconazole, diazaborine, benomyl, methotrexate, and other drugs; expression is induced in cells
treated with the mycotoxin patulin; relocalizes from nucleus to plasma membrane upon DNA replication stress
YNR055C HOL1 Mutations in membrane-spanning domains permit cation and histidinol uptake
YIL120w QDR1 Involved in spore wall assembly; sequence similarity to DTR1 and QDR3, and the triple mutant dtr1 qdr1 qdr3 exhibits
reduced dityrosine fluorescence relative to the single mutants; required for resistance to quinidine, ketoconazole,
fluconazole, and barban; has a paralog, AQR1, that arose from the whole genome duplication
YIL121w QDR2 Exports and is regulated by copper; has broad substrate specificity and can transport many mono- and divalent cations;
transports a variety of drugs and is required for resistance to quinidine, barban, cisplatin, and bleomycin; contributes to
potassium homeostasis
YBR043c QDR3/AQR2 Has a role in polyamine homeostasis; involved in spore wall assembly; sequence similarity to DTR1 and QDR1, and the
triple mutant dtr1 qdr1 qdr3 exhibits reduced dityrosine fluorescence relative to the single mutants; expression is
up-regulated under polyamine stress; required for resistance to quinidine, barban, cisplatin, and bleomycin
YLL028w TPO1 Polyamine transporter that recognizes spermine, putrescine, and spermidine; catalyzes uptake of polyamines at alkaline
pH and excretion at acidic pH; phosphorylation enhances activity and sorting to the plasma membrane
YGR138c TPO2 Polyamine transporter, specific for spermine; localizes to the plasma membrane; transcription is regulated by Haa1p;
has a paralog, TPO3, that arose from the whole genome duplication
YPR156c TPO3 Polyamine transporter, specific for spermine; localizes to the plasma membrane; has a paralog, TPO2, that arose from
the whole genome duplication
YOR273c TPO4 Polyamine transporter that recognizes spermine, putrescine, and spermidine; localizes to the plasma membrane
YHR048w YHK8 Expression is up-regulated in cells exhibiting reduced susceptibility to azoles
aFor a comprehensive list of compounds to which each gene confers resistance (see Sá-Correia et al., 2009) and the more recent literature compiled for each gene
in the Saccharomyces Genome Database.
copper homeostasis (an important substrate for several intracel-
lular redox reactions) might also provide an explanation for the
involvement of Qdr2 in the oxidative stress response (Rios et al.,
2013). Interestingly, the Qdr2 homolog in C. glabrata, CgQdr2,
although conferring resistance to the same drugs as its S. cerevisiae
counterpart, was not found to confer an advantage to C. glabrata
or S. cerevisiae cells grown under K+ limitation, nor did it com-
plement the S. cerevisiae qdr2 null mutant phenotype under these
conditions (Costa et al., 2013a).
Qdr3, which is involved in spore wall assembly together
with its close homologs Dtr1 and Qdr1 (Lin et al., 2013), was
recently suggested to have a still undetermined role in respiration,
with qdr3 null mutants displaying a respiratory deficiency under
glucose depletion (Dikicioglu et al., 2008). The same authors
later employed an integrated transcriptomics and metabolomics
approach to find that cells lacking Qdr3 (as well as the pleiotropic
drug resistance transcription factor Pdr3) are able to rearrange
their metabolism and accumulate intracellular glucose, glycerol,
and inorganic phosphate when grown under glucose or ammo-
nium limitation, in what the authors argue is an alternative
defense mechanism and a pre-adaptive response to the loss of
the drug resistance genes PDR3 and QDR3 (Dikicioglu et al.,
2013). These findings were not replicated for either Qdr1 or Qdr2,
indicating a wider role of Qdr3 in cellular physiology. However,
one of the most significant physiological roles of Qdr3 is proba-
bly its involvement in the export and homeostasis of polyamines
(Teixeira et al., 2011). Polyamines are essential organic cations
that are implicated in the regulation of nucleic acid and protein
synthesis, as well as the gating of several ion channels (Cohen,
1998). Unlike in higher eukaryotes, polyamine transport in the
yeast S. cerevisiae has been characterized in recent years (Igarashi
and Kashiwagi, 2010), and four transporters among the DHA1
family were first described as polyamine transporters, Tpo1,
Tpo2, Tpo3, and Tpo4 (Tomitori et al., 1999; Albertsen et al.,
2003; Uemura et al., 2005). Qdr3 was also found to be involved
in the homeostasis of the polyamines spermine and spermi-
dine (but not putrescine), with QDR3 expression leading to a
drop in the intracellular accumulation of spermidine and to a
decrease in spermidine-induced disruption of the plasma mem-
brane potential (Teixeira et al., 2011). Interestingly, although both
Qdr2 and Qdr3 are determinants of resistance to polyamines and
share several of their putative drug substrates (Sá-Correia et al.,
2009), Qdr3 has no described role in mono- and divalent cation
homeostasis, while Qdr2 is apparently not involved in polyamine
transport (Teixeira et al., 2011).
Tpo1-4 confers resistance to toxic concentrations of the
polyamines spermine, spermidine and putrescine (Tomitori et al.,
2001). Tpo1 is the DHA1 transporter with the widest described
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Table 2 | List of MDR/MXR-MFS transporters encoded in the genome of S. cerevisiae, belonging to the DAG family, gene product descriptions
are based on the information listed for each gene in the Saccharomyces Genome Database.a
Gene Name Gene product description
DHA2 SUBFAMILY
YML116w ATR1/SNQ1 Required for resistance to aminotriazole and 4-nitroquinoline-N-oxide; has a paralog, YMR279C, that arose from the
whole genome duplication; putative boron exporter; protein abundance increases in response to DNA replication stress
YGR224w AZR1 Involved in resistance to weak acids and azole drugs such as ketoconazole and fluconazole
YPR198w SGE1/NOR1 Acts as an extrusion permease; partial multicopy suppressor of gal11 mutations
YMR088c VBA1 Permease of basic amino acids in the vacuolar membrane
YBR293w VBA2 Permease of basic amino acids in the vacuolar membrane
YCL069w VBA3 Permease of basic amino acids in the vacuolar membrane; has a paralog, VBA5, that arose from a segmental duplication
YDR119w VBA4 Proposed role as a basic amino acid permease based on phylogeny; GFP-fusion protein localizes to vacuolar membrane;
physical interaction with Atg27p suggests a possible role in autophagy
YKR105c VBA5 Involved in amino acid uptake and drug sensitivity; has a paralog, VBA3, that arose from a segmental duplication
YOR378w Putative paralog of ATR1 but not required for boron tolerance
YMR279c Putative boron transporter involved in boron efflux and resistance; overexpression mutant but not null mutant displays
boron tolerance phenotype; heat-induced gene; has a paralog, ATR1, that arose from the whole genome duplication
ARN SUBFAMILY
YHL040c ARN1 Transporter for siderophore-iron chelates; responsible for uptake of iron bound to ferrirubin, ferrirhodin, and related
siderophores; protein increases in abundance and relocalizes to the vacuole upon DNA replication stress
YHL047c ARN2/TAF1 Responsible for uptake of iron bound to the siderophore triacetylfusarinine C
YRL065w SIT1/ARN3 Ferrioxamine B transporter; transcription is induced during iron deprivation and diauxic shift; potentially phosphorylated
by Cdc28p
YOL158c ENB1/ARN4 Endosomal ferric enterobactin transporter; expressed under conditions of iron deprivation; expression is regulated by
Rcs1p and affected by chloroquine treatment
GEX SUBFAMILY
YCL073c GEX1 H+:glutathione antiporter; localized to the vacuolar and plasma membranes; imports glutathione from the vacuole and
exports it through the plasma membrane; has a role in resistance to oxidative stress and modulation of the PKA
pathway; has a paralog, GEX2, that arose from a segmental duplication
YKR106w GEX2 H+:glutathione antiporter; localized to the vacuolar and plasma membranes; expressed at a very low level; potential role
in resistance to oxidative stress and modulation of the PKA pathway; has a paralog, GEX1, that arose from a segmental
duplication
aFor a comprehensive list of compounds to which each gene confers resistance (see Sá-Correia et al., 2009) and the more recent literature compiled for each gene
in the Saccharomyces Genome Database.
range of compounds to which it can confer chemoprotection
(Sá-Correia et al., 2009). However, one question that has often
been asked is whether Tpo1 confers resistance to all of these
unrelated compounds directly or indirectly through its role in
polyamine homeostasis. One important contribution to answer
this question was the demonstration that Tpo1-mediated sper-
mine and spermidine export plays a role in the response to oxida-
tive stress by changing the intracellular concentrations of these
polyamines to control the timing of central components of that
response (induction of antioxidant proteins, cell cycle delay, etc.)
(Kruger et al., 2013). These observations constitute an important
argument in favor of an indirect role of several MDR/MXR-
MFS transporters in multidrug and stress resistance, at least
partially through an indirect regulation of the stress response
machinery via a metabolic control mechanism. Interestingly,
although the Hol1 transporter does not have an attributed role
in MDR/MXR, specific HOL1 mutations have been shown to
enhance the ability of yeast cells to import histidinol (a precur-
sor of histidine) and mono- and divalent cations (Wright et al.,
1996).
The DAG family
The DAG family in S. cerevisiae includes 16 proteins, encoded by
ATR1, AZR1, SGE1, VBA1, VBA2, VBA3, VBA4, VBA5, YMR279c,
and YOR378w (the DHA2 subfamily, in general less well char-
acterized than the DHA1), ARN1, ARN2, SIT, and ENB1 (ARN
subfamily), GEX1 and GEX2 (GEX subfamily) (Table 2) (Sá-
Correia et al., 2009; Dias and Sa-Correia, 2013). Unlike the
members of the DHA1 family, the majority of the DHA2 pro-
teins have not yet been associated with drug resistance. Only
three proteins, Atr1, Azr1, and Sge1, have been shown to provide
broad chemoprotection (Sá-Correia et al., 2009). Among them,
only Atr1 has a proposed physiological role as the main boron
exporter in yeast (Kaya et al., 2009). Conversely, several DHA2
proteins have been assigned substrates of biological significance,
but have not been described as resistance determinants. Following
the identification of ATR1 in a genetic screen for boron toler-
ance (Kaya et al., 2009), YMR279c, a paralog of ATR1, was also
suggested to encode a boron exporter and be involved in boron
tolerance, but not YOR378w, another paralog of ATR1 (Bozdag
et al., 2011). Interestingly, ATR1 was also suggested to be involved
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in the response to DNA replication stress, with its protein abun-
dance being increased following MMS treatment (Tkach et al.,
2012). Also, YOR378w has been implicated in the TOR pathway
in a microarray-based high-throughput screen (Butcher et al.,
2006). Overexpression of YPR378w was found to significantly
increase the sensitivity of yeast cells to rapamycin, the inhibitor of
the TOR pathway, with possible implications in multiple nutrient
signaling pathways, cell growth and metabolic regulation.
The DHA2 subfamily also includes five transporters that have
been postulated as vacuolar basic amino acids permeases, Vba1,
Vba2, Vba3, Vba4, and Vba5. Vba1-3 has been shown to mediate
the import of histidine and lysine into the vacuole, while Vba2
is also able to catalyze the vacuolar uptake of arginine (Shimazu
et al., 2005). Although Vba4 is also localized to the vacuolar
membrane and exhibits high sequence similarity to Vba1-3, it
has not been shown to be involved in the vacuolar uptake of
basic amino acids and its physiological role has not yet been
demonstrated. Vba5, although a very close homolog of Vba3, is
localized to the plasma membrane instead of the vacuolar mem-
brane, and catalyzes the uptake of lysine and arginine into the
cell (Shimazu et al., 2012). Interestingly, although the role of
these MDR/MXR-MFS transporters in chemical stress resistance
has been investigated, only VBA5 was associated with MDR, its
overexpression leading to increased susceptibility to 4-NQO and
quinidine (Shimazu et al., 2005, 2012).
The ARN family, recently found to share an evolutionary root
with the DHA2 subfamily and integrated in the newly named
DAG family (Dias and Sa-Correia, 2013), encodes four proteins
involved in the uptake of siderophore-iron chelates that have
been characterized for several years now, Arn1 (Heymann et al.,
2000a), Arn2 (Heymann et al., 1999), Sit1 (Lesuisse et al., 1998),
and Enb1 (Heymann et al., 2000b). Themain natural substrates of
Arn2 and Enb1 are the bacterial enterobactin and triacetylfusari-
nine C, respectively (Heymann et al., 1999, 2000b), with high
siderophore substrate specificity, while Arn1 and Sit1 exhibit a
broader and overlapping range of siderophore substrates, includ-
ing several ferrichromes (Lesuisse et al., 1998; Heymann et al.,
2000a; Haas et al., 2008). However, other possible roles for these
proteins have been proposed. For example, Arn1 was shown to
relocalize from the nucleus to the vacuole [although again the
localization under control conditions does not match the local-
ization predicted by Huh et al. (2003)] and increase in abundance
under DNA replication stress induced by the same agents, sug-
gesting a role in DNA damage response pathways (Tkach et al.,
2012).
Although the GEX proteins share a high sequence similarity
to the ARN transporters and are dependent on the iron respon-
sive transcription factor Aft2, they are apparently not involved
in siderophore transport and have instead a physiological role
as glutathione extrusion pumps, mostly localized at the vacuo-
lar membrane but also at the plasma membrane (Dhaoui et al.,
2011; Thorsen et al., 2012). Null mutant gex1gex2 strains are defi-
cient in pH and glutathione homeostasis and are hypersensitive
to H2O2, while overexpression of Gex1 resulted in modulation
of the cAMP/PKA and PKC1-MAPK signaling pathways, hinting
at a connection between iron, redox equilibrium, and the oxida-
tive stress response (Dhaoui et al., 2011). Furthermore, Gex1 was
also suggested to mediate cadmium efflux at the plasma mem-
brane and participate in cadmium detoxification, either alone or
as a complex with glutathione (Dhaoui et al., 2011). Given the
role of glutathione in heavy metal detoxification and protection
against oxidative stress, the natural physiological roles of the GEX
proteins might, as previously described for Tpo1 (Kruger et al.,
2013), indirectly regulate the stress response machinery, possibly
through hierarchical signaling pathways.
EVOLUTION OF THE DHA1 AND DAG FAMILIES
Over the past few years, new clues on the evolution of
MDR/MXR-MFS genes in yeast species belonging to the sub-
phylum Saccharomycotina (most commonly known as the
Hemiascomycetes) have been obtained, based on the increas-
ing abundance of available genome sequences, which may help
to understand several of the issues raised regarding the action
of such transporters (Gbelska et al., 2006; Dias et al., 2010;
Dias and Sa-Correia, 2013). Phylogenetic and gene neighbor-
hood approaches were combined to reconstruct the evolution of
DHA1 genes encoded in the genome of 13 hemiascomycete yeasts
(of species S. cerevisiae, S. bayanus, S. castellii, Candida glabrata,
Kluyveromyces polysporus, Zygosaccharomyces rouxii, S. kluyveri,
K. waltii, K. thermotolerans, K. lactis, Eremothecium gossypii,
Debaryomyces hansenii, Yarrowia lipolytica), with the identifica-
tion of 10 main gene lineages (Dias et al., 2010). The construction
of a DHA1 phylogenetic tree identified 20 clusters, 11 of which
did not contain any S. cerevisiaemembers. The chromosome envi-
ronments where DHA1 genes reside was found to be remarkably
conserved in the hemiascomycete yeast species, with the exception
of the lineage containing FLR1 homologs (Dias et al., 2010). Gene
duplication and loss were suggested to be the major forces driving
the evolution of the DHA1 protein family (Dias et al., 2010).
The evolution of DAG genes encoded in the genome of
31 hemiascomycetous yeast strains from 25 species (S. cere-
visiae, S. paradoxus, S. mikatae, S. bayanus, S. kudriavzevii,
S. castelli, C. glabrata, K. polysporus, Z. rouxii, S. kluyveri,
K. waltii, K. thermotolerans, K. lactis, E. gossypii, Candida albicans,
Candida dubliniensis, Candida tropicalis, Candida parapsilosis,
Lodderomyces elongisporus, Candida guilliermondii, D. hansenii,
Pichia stipitis, Candida lusitaniae. P. pastoris, Y. lipolytica) was
also reconstructed (Dias and Sa-Correia, 2013). The phylogenetic
tree obtained also identified 20 clusters, with 11 of them lack-
ing S. cerevisiaemembers. Gene neighborhood analysis suggested
that gene duplication and loss as well as lateral transfers were the
most important driving forces in the evolution of the hemias-
comycetous DAG genes (Dias and Sa-Correia, 2013). Lateral gene
transfer is proposed to have affected the lineages containing the
following S. cerevisiae DAG genes: SGE1, VBA3, VBA5, VBA4,
VBA2, GEX1/GEX2, ARN2, and YOR378W. The hypothesis that
an abundant number of species-to-species transference of DAG
genes has occurred during the evolution of the hemiascomycete
yeasts is consistent with the fact that the majority of S. cere-
visiae DAG genes does not show synteny with the corresponding
homologs encoded in early divergent Saccharomycetaceae species
(Dias and Sa-Correia, 2013). Also, with the exception of ATR1,
YMR279C, AZR1, VBA1, and VBA4, S. cerevisiae DAG genes
reside in sub-telomeric regions, the preferential chromosomal
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residence of horizontally acquired genes (Fairhead and Dujon,
2006).
Although the sequences comprised in each phylogenetic clus-
ter for both DHA1 and DAG families are significantly conserved,
suggesting that each cluster might contain genes with a specific
biological function in common, in several cases we could not
find a direct connection between sequence similarity and func-
tion. Qdr1 and Qdr2 are good examples, with extremely high
amino acid conservation, and yet their main proposed physiolog-
ical functions (e.g., involvement in spore wall assembly for Qdr1
Lin et al., 2013 and the role in boron extrusion and homeostasis
of several cations for Qdr2 Vargas et al., 2007; Rios et al., 2013)
are not overlapping. Another example is the ARN transporters
and their siderophore substrate specificity (Lesuisse et al., 1998;
Heymann et al., 1999, 2000a,b), which cannot be immediately
explained by the observed phylogenetic relationships (Figure 1).
Nevertheless, from the consistent retention of DHA1 and DAG
genes during the evolution of the Hemiascomycetes, it is likely
that the encoded proteins may be important for yeast fitness
and survival in the diverse range of ecological niches occupied
by these microorganisms in nature. Also, the fact that the ARN
and GEX transporters have not been specifically implicated in
MDR/MXR (with the exception of a few unexploited phenotypes
of altered fitness and gene expression in response to chemical
stress, identified in genome-wide screens) further hints at a more
complex involvement of these MDR/MXR-MFS transporters in
chemoprotection.
CLUES ON THE FUNCTIONAL ANALYSIS OF DHA1/DAG
TRANSPORTERS BASED ON THEIR TRANSCRIPTIONAL
REGULATION UNDER ENVIRONMENTAL CHALLENGES OR
STRESS
During the past few years, much information has been gath-
ered on the transcriptional regulation of the genes encoding
DHA1/DAG transporters in S. cerevisiae, mostly coming from
genome-wide experiments. This information, gathered in the
YEASTRACT database (www.yeastract.com) (Teixeira et al., 2006,
2014) highlights interesting hypotheses for the function of the
DHA transporters, not only in the multidrug resistance context,
but also within the perspective of their physiological roles. It is
interesting to note that the regulation of DHA1/DAG genes is
far more intricate that initially imagined. Beyond the expected
role of MDR transcription factors, a number of stress response
and nutrient availability transcription factors have been found,
throughout the years, to regulate DHA1/DAG genes. Indeed, the
number of regulatory associations with DHA1/DAG genes involv-
ing transcription factors virtually not related to MDR is much
higher than that involving recognized MDR transcription fac-
tors, even when considering only direct regulatory associations,
based onDNA-binding evidence. As detailed below, the transcrip-
tional regulation by non-MDR transcription factors has, in a few
cases, been seen to be consistent with the physiological role of the
DHA1/DAG transporters, suggesting that there is much more to
learn from the clues provided by transcription regulation data.
In what concerns multidrug resistance, 23 out of the 28
DHA1/DAG transporters in S. cerevisiae are known to be regu-
lated by at least oneMDR-related transcription factor, specifically,
all of the DHA1 transporters and nearly 70% of the DAG trans-
porters (Figure 2A). Remarkably, Pdr1 was found to regulate
nearly 60% of the DHA1/DAG genes. Transporters that have been
more clearly linked to resistance to a wider range of drugs are
indeed those that are regulated by a higher number of MDR tran-
scription factors. This is the case for FLR1 and TPO1, which are
regulated by Yrr1, Yrm1, Stb5, Pdr1 and Pdr3. In particular, the
FLR1 regulation is a paradigmatic case of study. Its regulation
is highly complex, being controlled, for example, under man-
cozeb stress by at least four transcription factors (Teixeira et al.,
2008), two of which, Pdr3 and Yrr1, are linked to multidrug resis-
tance, and two are involved in stress response, Yap1 and Rpn4.
A more detailed analysis of this network, based on a systems
biology approach, has highlighted even further the possible influ-
ence of a fifth transcription factor (Teixeira et al., 2010), which
remains unidentified. It is also interesting to point out the cases of
Hol1, Vba2, Vba4, Yor378w, Arn1-4 and Gex1 which, despite the
absence of evidence for a role in MDR/MXR, are indeed regulated
by MDR transcription factors (Figure 2A).
All of the DHA1/DAG genes have been found to be regulated
by, at least, seven stress related transcription factors, with the
transcription factors Sfp1 (86%), Msn2 (71%), Msn4 (64%), and
Yap1 (61%) regulating more than 60% of the DHA1/DAG genes
(Figure 2B). Msn2 and Msn4 are the key regulators of the gen-
eral stress response, while Yap1 is involved in the oxidative stress
response and also in specific cases of drug resistance, and Sfp1
is involved in ribosome biogenesis and, indirectly, in resistance
to many stress conditions. The regulatory associations involv-
ing Rpn4, a transcription factor that controls proteosomal genes
and that is implicated in the oxidative stress response and DNA
repair (Jelinsky et al., 2000; Karpov et al., 2013), in particular
induced by the genotoxic agent MMS (Spasskaya et al., 2014),
are also of interest. Rpn4 has been shown to regulate 43% of all
DHA1/DAG genes, including the 4 genes (ARN1, ATR1, AQR1,
and FLR1) whose expression and/or localization was found to
change in response to MMS treatment leading to replicative stress
(Tkach et al., 2012). Many more stress related transcription fac-
tors, although falling out of this analysis since they only regulate
less than six of the DHA1/DAG genes, may also provide interest-
ing clues on the function of this family of transporters. This is the
case, for example, for Haa1, a key regulator of acetic acid stress
response (Fernandes et al., 2005), which has been reported to con-
trol the expression of TPO2 and TPO3 in response to acetic acid
(Mira et al., 2010, 2011), acetaldehyde (Aranda and del Olmo,
2004) and copper stress (Keller et al., 2001), and also to affect the
basal expression of YMR279c (Reimand et al., 2010).
All but one of the DHA1/DAG genes are also regulated by
nutrient availability transcription factors. Thirteen transcription
factors involved in the response to amino acid availability have
been found to regulate 70% of the DHA1/DAG genes. Among
these transcription factors, Gcn4 and Bas1 stand out as the
two that regulate the majority (more than 60%) of these genes
(Figure 2C). Gcn4 is an activator of amino acid biosynthetic
genes, in response to amino acid starvation, while Bas1 regulates
the expression of genes in the purine and histidine biosynthe-
sis pathways. In some cases, a clear link between the function
of the DHA1/DAG genes and amino acid homeostasis has been
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FIGURE 2 | Transcriptional regulatory networks that control the
expression of DHA/DAG genes, considering the subgroups of
transcription factors known to be involved in multidrug resistance (A), in
stress response (B), lipid metabolism (C), or in the response to amino
acid (D) and carbon source (E) availability. The displayed regulatory
associations are according to the data present in the Yeastract database
(www.yeastract.com, Teixeira et al., 2006, 2014), as of February 2014. Arrows
indicate the experimental basis of the documented regulatory associations,
either expression evidence (blue arrows) or DNA-binding evidence (red
arrows). Bold arrows indicate the cases in which the regulatory association
was found to take place in response to the environmental condition
considered in each subgroup of transcription factors.
established. This is the case for Aqr1, proposed to play a role
in the extrusion of amino acids, particularly homoserine and
threonine (Velasco et al., 2004). The Vba transporters have also
been described as vacuolar membrane amino acid transporters
(Shimazu et al., 2005), while Qdr2 has been shown to affect
amino acid homeostasis, especially in cells experiencing leucine
limitation (Vargas et al., 2007). The remaining DHA1/DAG
transporters have no described link to amino acid homeostasis.
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However, the fact that they are regulated, at the transcriptional
level, by several transcription factors controlling amino acid
homeostasis, suggests that theymay also play a role in this context.
This appears to be especially the case for Tpo2, Tpo4, and Atr1,
which are each regulated by five of these transcription factors.
Twenty-six transcription factors linked to carbon source avail-
ability have been shown to regulate at least one DHA1/DAG gene.
It is interesting to point out that the transcription factors of this
group that regulate a higher number of DHA1/DAG genes are
Mig3 (61%), Hap2 (36%), and Tye7 (32%). Mig3 plays a major
role in carbon catabolite repression and ethanol response, but is
also involved in the response to toxic agents, while Hap2 is one of
the key regulators of respiration and Tye7 is an activator of gly-
colytic gene expression. Among the 27 DHA genes regulated by
carbon source related transcription factors, eight are regulated by
five or more of these transcription factors, including Atr1 (5 TFs),
Vba4 (5 TFs), Arn3 (6 TFs), Arn4 (5 TFs), Ymr279c (7 TFs), Hol1
(5 TFs), Tpo1 (5 TFs), and Aqr1 (12 TFs) (Figure 2C). Very little
is known however on the role of DHA1/DAG transporters in car-
bon metabolism, although recent studies have suggested a respi-
ratory deficiency of qdr3 null mutants under glucose deprivation
(Dikicioglu et al., 2008).
Another analysis of interest concerns the regulation involv-
ing lipid metabolism-related transcription factors. The overall
role of ABC transporters in membrane lipid homeostasis, and
consequently in stress tolerance and drug resistance, has been
widely discussed in recent years (Panwar et al., 2008; Shahi and
Moye-Rowley, 2009; Peetla et al., 2013). In fact, fluctuations in
membrane composition are known to alter drug distribution and
accumulation, and also to affect the localization and function of
MDR pumps. The involvement of MDR/MXR transporters in the
regulation of membrane composition has been shown to provide
an important contribution to MDR/MXR resistance (Shahi and
Moye-Rowley, 2009). Although the same type of association has
never been established for MDR/MXR-MFS transporters, the fact
that 9 lipid metabolism-related transcription factors regulate 24
out of the 28 might be indicative of a similar, still unidentified,
role for MDR/MXR-MFS transporters in membrane lipid home-
ostasis or lipid-based signaling. Particularly noteworthy are the
transcription factors Spt23, Cst6, and Pip2 which regulate 46,
32, and 32% of the total number of DHA/DAG genes. Spt23 is
involved in the regulation of the single yeast fatty acid desat-
urase Ole1, while Cst6 and Pip2 are regulators of oleate responsive
genes. Interestingly, the action of Spt23 in its target DHA/DAG
genes was found to occur under heat shock (Auld et al., 2006),
while that of Pip2 upon ARN2, TPO1, and TPO4 was registered
in cells growing on oleate as carbon source (Smith et al., 2007).
It also appears noteworthy that many of the regulatory asso-
ciations found so far to involve DHA1/DAG genes have been
reported under non-stress conditions. Figures 2A–E highlight in
bold the cases in which the reported association is known to take
place under the stress in which the corresponding group of tran-
scription factors is known to act. This observation suggests that
the control of the basal expression of the DHA1/DAG genes is
also crucial for the maintenance of cellular homeostasis, even
under non-stressing conditions, strongly pointing out that these
so-called “drug transporters” must serve much more important
and wider roles in cell physiology, which are still far from being
fully understood.
Finally, it is important to point out that these analyses are
based on Yeastract information “as is.” This is relevant because the
interactions reported therein come from different sources and rely
on different experimental approaches. Interactions can be based
on indirect (e.g., transcriptomic analyses) or direct (e.g., ChIP
data) evidences, and the number of independent studies support-
ing each regulatory interaction can vary greatly. Here we have
opted to show all interactions described for each TF-target gene
considered, although we distinguish between expression evidence
and DNA-binding evidence (red arrows vs. blue arrows, respec-
tively; Figures 2A–E). Therefore, the regulatory networks that are
discussed here should be considered with this in mind, and the
level of confidence of each interaction can be assessed in Yeastract
by the readers whenever relevant.
FUTURE PERSPECTIVES AND CONCLUDING REMARKS
Yeast MDR/MXR-MFS transporters have been traditionally
characterized as transporters of a significantly wide spectrum
of structurally unrelated cytotoxic compounds. However, their
prevalence and apparent redundancy has led to a longstanding
debate regarding the natural function of these transporters in
the cell, and on whether their action in the context of chemo-
protection and stress resistance is direct, indirect or a combi-
nation of both (Sá-Correia et al., 2009). Mounting evidence
seems to favor the latter hypothesis, and even for ABC trans-
porters, the paradigmatic drug pumps that include the well-
characterized human P-glycoprotein (Kartner et al., 1983), there
is an increasing acknowledgement of the indirect contribution
of these transporters to the resistant phenotype through the
control of plasma membrane potential and membrane lipid
homeostasis, which in turn can affect drug delivery to intra-
cellular targets and its accumulation (see Prasad and Panwar,
2004; Panwar et al., 2008; Shahi and Moye-Rowley, 2009; Peetla
et al., 2013) for reviews on this topic). The experimental evidence
reviewed here regarding the yeast MDR/MXR-MFS transporters
highlights a significant number of recent studies unveiling new
and unexpectedly complex roles of these transporters that are
shown to contribute to their role in MDR/MXR, in particular
through metabolic regulation of the stress response machinery,
in addition to the previously proposed action on the control of
membrane potential and/or internal pH (Roepe et al., 1996; Sá-
Correia et al., 2009). Interestingly, phylogenetic analyses of the
DHA1 and DHA2 subfamilies in other hemiascomycete yeasts
have identified several functionally characterized transporters
presumably involved in the MDR/MXR phenomenon (Gbelska
et al., 2006; Dias et al., 2010; Dias and Sa-Correia, 2013). These
include CgTpo3, which plays a role in polyamine homeosta-
sis and azole drug resistance (Costa et al., 2014), mirroring its
S. cerevisiae homolog Tpo3; Nag3, and Nag4, which catalyze the
uptake of N-acetylglucosamine in Candida albicans and are also
involved in drug sensitivity and virulence (Yamada-Okabe and
Yamada-Okabe, 2002; Sengupta and Datta, 2003; Wendland et al.,
2009); Ffz1 and Ffz2, two characterized importers of fructose in
Zygosaccharomyces rouxii (Leandro et al., 2011) (and Z. bailli for
Ffz1, Pina et al., 2004) with no known role in MDR/MXR; and
www.frontiersin.org May 2014 | Volume 5 | Article 180 | 11
dos Santos et al. Yeast MFS transporters involved in MDR/MXR
Knq1, a Kluyveromyces lactis transporter that is involved in iron
homeostasis, drug resistance and oxidative stress response under
the control of KlYap1 (Takacova et al., 2004; Imrichova et al.,
2005; Marchi et al., 2007), the K. lactis homolog of S. cerevisiae’s
Yap1. Interestingly, although KNQ1 shares some sequence iden-
tity with ATR1, there is no close homolog in S. cerevisiae, with the
exception of S. cerevisiae JAY-291, a fully sequenced strain that is
widely used in bioethanol production (Argueso et al., 2009). The
functional characterization of DHA proteins identified in other
yeast species that no longer have a close homolog encoded in
the genome of S. cerevisiae might also contribute to elucidate the
physiological relevance of these transporters.
The extension of the current knowledge on yeast MDR/MXR
transporters to pathogenic yeasts, in particular Candida species,
is another crucial area that in the future is expected to con-
tribute to the management of the rising number of drug resistant
fungal infections. However, the MFS family of multidrug trans-
porters in Candida species remains largely uncharacterized, and
there is in general a much stronger association between clini-
cal acquisition of antifungal drug resistance and the expression
of ABC drug pumps (Gaur et al., 2008; Cannon et al., 2009).
The first MDR/MXR-MFS transporter to be characterized from a
pathogenic fungus was the paradigmatic Mdr1 protein in C. albi-
cans, a close homolog of S. cerevisiae Flr1 and a determinant
of resistance to azole drugs, benomyl, methotrexate etc. (Fling
et al., 1991; Ben-Yaacov et al., 1994). More recently, C. glabrata
homologs of DHA1 Qdr2 (Costa et al., 2013a), Aqr1 (Costa
et al., 2013b), and Tpo3 (Costa et al., 2014) have been impli-
cated in antifungal drug resistance, while the homolog of Aqr1
and Tpo3 were further shown to have a role in acetic acid
resistance and polyamine homeostasis, respectively (Costa et al.,
2013b, 2014). In phytopathogenic fungi, which constitute an
important problem in crop protection, MDR/MXR-MFS trans-
porters such as BcMfs1 from Botrytis cinerea (Hayashi et al.,
2002) andMgMfs1 fromMycosphaerella graminicola (Roohparvar
et al., 2007, 2008) have also been shown to be involved in resis-
tance to natural plant toxins and fungicides. Altogether, the role
of many DHA transporters from fungal species was found to,
at least partially, mirror their S. cerevisiae homologs, highlight-
ing the relevance of studies in the model yeast to elucidate the
regulation and functional role of these transporters in other
species.
Further characterization of drug resistance MFS proteins in
pathogenic yeasts or phytopathogenic fungi will benefit from
studies in S. cerevisiae, in particular from transcriptional data
that might help elucidate the putative physiological roles of these
transporters. Although it remains to be clarified if the complex
transcriptional networks previously described for S. cerevisiae
have parallels in other yeasts, recent findings regarding the tran-
scriptional regulation of ScFLR1 orthologs in C. albicans and
C. glabrata (CaMDR1 and CgFLR1, respectively) show that it is at
least partially similar to that in S. cerevisiae (Gulshan and Moye-
Rowley, 2007), whereas the transcriptional control of CgQdr2
and CgTpo3 (Costa et al., 2013a, 2014) appears to differ from
that of their S. cerevisiae counterparts. The recent finding on
MDR/MXR-MFS transporters in Candida species will be the
focus of another review in this research topic (see Costa et al. in
this Research Topic).
The knowledge gathered in yeast MDR/MXR-MFS trans-
porters can also be extrapolated to other systems and less
accessible higher eukaryotes such as plants. Abiotic stress is an
important contributor to loss of plant productivity worldwide
under agricultural conditions. The clarification of the mecha-
nisms underlying MDR/MXR in plants will be instrumental in
paving the way for the development of efficient strategies to
improve crop tolerance to abiotic stress, in particular regard-
ing the potential role of MDR/MXR transporters in the plant
response to heavy-metal contamination, high salinity, pesticides,
and other xenobiotic compounds. Considerable progress has been
made on the characterization of plant ABC transporters, which
have been shown to play a pivotal role in numerous physi-
ological processes (van den Brule and Smart, 2002), however
the functional significance of MFS transporter genes in plants
remains largely unknown (discussed elsewhere in this research
topic). Given the conservation of transport mechanisms from
S. cerevisiae to higher eukaryotes, Tpo1 homologs encoding puta-
tive plasma membrane MFS transporters from the plant model
Arabidopsis thaliana were analyzed to uncover new roles for
these transporters in plant abiotic stress tolerance (Cabrito et al.,
2009). This led to the identification of Zifl1, the first eukaryotic
MFS transporter identified as a multidrug resistance determi-
nant. ZIFL1 transcription levels were found to be elevated in
plants treated with the herbicide 2,4-D, and heterologous expres-
sion in yeast complemented the sensitivity phenotype in tpo1
null mutant cells stressed with 2,4-D (Cabrito et al., 2009). This
study is a proof of concept that validated the combined use of
the two model systems, S. cerevisiae and A. thaliana, to uncover
novel roles for plant MFS transporters, which may open new
avenues for the development of efficient strategies to improve
crop productivity or decontaminate polluted soils.
In recent years, the use of genome-wide approaches in the
model yeast S. cerevisiae has significantly increased our knowl-
edge on the evolution, physiology and regulation of MDR/MXR-
MFS transporters, contributing to elucidate the mystery of the
redundancy and promiscuity of these transporters and their phys-
iological relevance. In the near future, more specialized global
approaches such as metabolomics and lipidomics are expected to
expand on the recent findings here reviewed, in particular regard-
ing the possible indirect role of these transporters in the regula-
tion of the stress response, either through metabolic regulation,
alteration of the plasmamembrane composition, or other mecha-
nisms. The exploitation of high-throughput technologies and the
knowledge gathered in yeast can prove invaluable to guide stud-
ies in pathogenic fungi, to develop more robust yeast strains for
biotechnological applications, and to improve crop protection,
with promising repercussions from medicine to biotechnology
and agriculture.
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